BMJ 2000;321:53 ( 1 July )

Letters

Optimum treatment for young women with breast cancer needs to be determined

The first 150 words of the full text of this article appear below.

EDITOR---The paper by Kroman et al on factors influencing the effect of age on prognosis in breast cancer has important implications for service delivery,1 increased amounts of chemotherapy being required for young women. The authors imply that only women at high risk received adjuvant chemotherapy. In all, 36.3% of their 867 patients under 35 were in the low risk group, an excess mortality being associated with not receiving chemotherapy.

We used the Yorkshire Cancer Registry (now part of the Northern and Yorkshire Cancer Registration and Information Service) to investigate the uptake of chemotherapy in this group of patients over the 15 years from 1980 to 1994 and determine its effect on survival.

Only 304 (19.8%) of the 1534 patients under 35 received adjuvant chemotherapy. Their overall five year survival rate was 60% (95% confidence interval 54.8 to 65.8) compared with 63% (60.6 to 66.0) in those who did not receive chemotherapy. When 41 patients who presented with overt . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Relevant Articles

More on burns after photodynamic therapy
D F Horrobin and Richard Bryce
BMJ 2001 322: 171. [Extract] [Full Text]

Factors influencing the effect of age on prognosis in breast cancer: population based study Commentary: much still to learn about relations between tumour biology, prognosis, and treatment outcome in early breast cancer
Niels Kroman, Maj-Britt Jensen, Jan Wohlfahrt, Henning T Mouridsen, Per Kragh Andersen, Mads Melbye, Andrew Tutt, and Gillian Ross
BMJ 2000 320: 474-479. [Abstract] [Full Text] [PDF]

This article has been cited by other articles:

  • Woehlck, H., Herrmann, D., Kaslow, O. (2003). Safe Use of Pulse Oximetry During Verteporphin Therapy. Anesth. Analg. 96: 177-178 [Abstract] [Full text]  
  • Horrobin, D F, Bryce, R. (2001). More on burns after photodynamic therapy. BMJ 322: 171a-171 [Full text]  



Access all current jobs at BMJ Group
Whats new online at Student 

BMJ
Listen to the latest 

BMJ Interview